Novo Nordisk postpones launch of intelligent insulin pens

Novo Nordisk was supposed to launch two intelligent insulin pens in the US and EU this year. Now, the Danish drug group calls in the products, which means that a broader launch will not happen before 2020 - one year later than planned.

Photo: Novo Nordisk/PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles